CAS: 18623-44-4 - 4-[5-(3,4-DIMETHOXY-BENZYLIDENE)-4-OXO-2-THIOXO-THIAZOLIDIN-3-YL]-BUTYRIC ACID

Formule : C₁₆H₁₆NO₅S₂

InChI : InChI=1/C16H17NO5S2/c1-21-11-6-5-10(8-12(11)22-2)9-13-15(20)17(16(23)24-13)7-3-4-14(18)19/h5-6,8-9H,3-4,7H2,1-2H3,(H,18,19)/p-1/b13-9-

Synonymes :

• 3-Thiazolidinebutanoic acid, 5-[(3,4-dimethoxyphenyl)methylene]-4-oxo-2-thioxo-, (5Z)-
• 4-[(5Z)-5-(3,4-Dimethoxybenzylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]butanoic acid
• 4-[(5Z)-5-(3,4-dimethoxybenzylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]butanoate
• 4-[5-(3,4-Dimethoxy-benzylidene)-4-oxo-2-thioxo-thiazolidin-3-yl]-butyric acid

iCRT-5

CAS : 18623-44-4

iCRT-5 is a potent inhibitor of the Wnt pathway. iCRT-5 has antiproliferative activity and can …

• Formule : C₁₆H₁₇NO₅S₂
• Degré de pureté : 99.68%
• Couleur et forme : Solid
• Masse moléculaire : 367.44

4-{5-[(3,4-Dimethoxyphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl}butanoic acid

CAS : 18623-44-4

4-{5-[(3,4-Dimethoxyphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl}butanoic acid is a potent inhibitor of the insulin receptor signaling pathway. It has been …

• Formule : C₁₆H₁₇NO₅S₂
• Degré de pureté : Min. 95%
• Masse moléculaire : 367.4 g/mol